- Home
- CZR vs PRAX Comparison
CZR vs PRAX Comparison
Compare CZR & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- PRAX
- Stock Information
- Founded
- CZR 1937
- PRAX 2015
- Country
- CZR United States
- PRAX United States
- Employees
- CZR N/A
- PRAX N/A
- Industry
- CZR Hotels/Resorts
- PRAX Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- PRAX Health Care
- Exchange
- CZR Nasdaq
- PRAX Nasdaq
- Market Cap
- CZR 4.4B
- PRAX 4.0B
- IPO Year
- CZR 1989
- PRAX 2020
- Fundamental
- Price
- CZR $20.95
- PRAX $189.56
- Analyst Decision
- CZR Buy
- PRAX Strong Buy
- Analyst Count
- CZR 16
- PRAX 13
- Target Price
- CZR $35.88
- PRAX $228.69
- AVG Volume (30 Days)
- CZR 11.2M
- PRAX 857.5K
- Earning Date
- CZR 10-28-2025
- PRAX 11-05-2025
- Dividend Yield
- CZR N/A
- PRAX N/A
- EPS Growth
- CZR N/A
- PRAX N/A
- EPS
- CZR N/A
- PRAX N/A
- Revenue
- CZR $11,369,000,000.00
- PRAX $7,463,000.00
- Revenue This Year
- CZR $3.17
- PRAX N/A
- Revenue Next Year
- CZR $2.85
- PRAX $44.43
- P/E Ratio
- CZR N/A
- PRAX N/A
- Revenue Growth
- CZR 0.87
- PRAX 364.98
- 52 Week Low
- CZR $18.25
- PRAX $26.70
- 52 Week High
- CZR $40.00
- PRAX $206.71
- Technical
- Relative Strength Index (RSI)
- CZR 49.59
- PRAX 58.41
- Support Level
- CZR $19.75
- PRAX $160.11
- Resistance Level
- CZR $20.78
- PRAX $197.50
- Average True Range (ATR)
- CZR 0.99
- PRAX 16.19
- MACD
- CZR 0.31
- PRAX -4.67
- Stochastic Oscillator
- CZR 79.09
- PRAX 73.49
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.